What does a dosage of 8 micrograms (mcg) per minute of norepinephrine indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine 8 mcg/min Dosing Context

A norepinephrine infusion rate of 8 mcg/min (not weight-based) represents a low-to-moderate absolute dose that falls well within the standard maintenance range for vasopressor support in septic shock. 1

Understanding the Dosing

The FDA-approved norepinephrine dosing provides critical context for interpreting 8 mcg/min 1:

  • Initial dose: 8-12 mcg/min (2-3 mL/min of standard 4 mcg/mL dilution) 1
  • Average maintenance range: 2-4 mcg/min (0.5-1 mL/min) 1
  • Your dose of 8 mcg/min: Falls at the lower end of initial dosing or upper end of maintenance dosing 1

Clinical Significance

This dose indicates moderate vasopressor requirements that do not yet warrant escalation to second-line agents. 2, 3

When to Consider Adding Vasopressin

Guidelines recommend adding vasopressin (0.03 units/min) when norepinephrine requirements remain elevated, but the specific threshold varies 4, 2:

  • Conservative approach: Add vasopressin when norepinephrine reaches 0.25 mcg/kg/min (approximately 15-20 mcg/min in a 70 kg patient) 5
  • Alternative threshold: Some centers initiate vasopressin at ≥50 mcg/min of norepinephrine 6
  • At 8 mcg/min: You are well below these thresholds and should continue norepinephrine monotherapy 2, 3

Weight-Based vs. Absolute Dosing

The 8 mcg/min dose you're asking about is an absolute rate, not weight-based. 1

For context, weight-based dosing equivalents 4:

  • Norepinephrine range: 0.1-2 mcg/kg/min in pediatrics 4
  • Adult septic shock: Typically 0.05-0.5 mcg/kg/min initially 4, 7
  • 8 mcg/min in a 70 kg patient: Equals approximately 0.11 mcg/kg/min (low-moderate dose) 1

Critical Monitoring at This Dose

At 8 mcg/min, you should have arterial line monitoring in place and be assessing for adequate tissue perfusion. 4, 2

Key monitoring parameters 4, 3:

  • Target MAP: ≥65 mmHg (higher targets of 80-85 mmHg only if chronic hypertension) 4, 3
  • Perfusion markers: Lactate clearance, urine output, mental status, skin perfusion 3
  • Fluid status: Ensure adequate volume resuscitation (≥30 mL/kg crystalloid) before escalating vasopressors 3, 1

Common Pitfalls to Avoid

Do not add dopamine for "renal protection" at this or any norepinephrine dose—this practice is strongly discouraged and provides no benefit. 4, 2

Additional pitfalls 4, 2:

  • Avoid phenylephrine as an alternative unless norepinephrine causes serious arrhythmias or cardiac output is documented to be high 4, 2
  • Do not use vasopressin as monotherapy—it must be added to norepinephrine, never used alone 2, 3
  • Suspect occult hypovolemia if requiring dose escalation beyond 20-30 mcg/min despite adequate initial resuscitation 1, 8

When to Escalate Beyond Norepinephrine Alone

If MAP remains <65 mmHg despite titrating norepinephrine upward from 8 mcg/min, continue increasing the dose before adding second agents. 2, 1

Escalation algorithm 2, 3:

  • Continue norepinephrine titration until reaching 15-50 mcg/min (institutional protocols vary) 2, 6
  • Add vasopressin 0.03 units/min if target MAP not achieved with norepinephrine alone 2, 3
  • Consider epinephrine as an alternative second agent 2, 3
  • Add dobutamine if persistent hypoperfusion despite adequate MAP and vasopressor support 4, 2

References

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vasopressor Management in Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vasopressor Use in Hypotensive Intubated Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vasopressor and Inotrope Therapy in Cardiac Critical Care.

Journal of intensive care medicine, 2021

Research

Refractory septic shock: efficacy and safety of very high doses of norepinephrine.

Methods and findings in experimental and clinical pharmacology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.